Literature DB >> 4383451

Evaluation of potential antirheumatic drugs in vitro using lymphocytes and epithelial cells. The selective action of indoxole, methyl glyoxal and chloroquine.

M W Whitehouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4383451     DOI: 10.1111/j.2042-7158.1967.tb09594.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  8 in total

Review 1.  Anti-inflammatory glucocorticoid drugs: reflections after 60 years.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

2.  About some biochemical properties of dimethylsulfoxide and three of its homologues: is the acidic function essential for nonsteroidal antiinflammatory activities?

Authors:  J P Famaey; M W Whitehouse
Journal:  Agents Actions       Date:  1974-10

3.  Concerning the pharmacological activity of non-steroid anti-inflammatory drugs: is the acidic function essential?

Authors:  M W Whitehouse; J P Famaey
Journal:  Agents Actions       Date:  1973-11

4.  Identification of a bacterial growth inhibitors from HeLa cells: a ketoaldehyde.

Authors:  B G Sparkes; C P Kenny
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

5.  Role of lymphocytes in non-immune experimental inflammation.

Authors:  J Garcia-Leme
Journal:  Agents Actions       Date:  1981-12

6.  About some possible anti-inflammatory properties of various membrane permeant agents.

Authors:  J P Famaey; M W Whitehouse
Journal:  Agents Actions       Date:  1975-05

7.  The proinflammatory function of lymphocytes in non-immune inflammation: effect of steroidal and non-steroidal anti-inflammatory agents.

Authors:  J G Leme; G H Bechara; L S Sudo
Journal:  Br J Exp Pathol       Date:  1977-12

Review 8.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.